Taylor & Francis Group
Browse

Supplementary Figure 1. Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis

Download (71.7 kB)
figure
posted on 2021-04-21, 08:10 authored by Rudolph M Navari, Gary Binder, Erminio Bonizzoni, Rebecca Clark-Snow, Silvia Olivari, Eric J Roeland
Daily Incidence of Breakthrough Emesis and/or Use of Rescue Medication and/or Significant Nausea (All Patients)

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC